197067530	197067530	CD	B-NP	O
|	|	NN	I-NP	O
RWPH	RWPH	NN	I-NP	O
|	|	NN	I-NP	O
20930664	20930664	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
670888	670888	CD	B-NP	O
|	|	CC	I-NP	O
5/21/2001	5/21/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/3/2001	9/3/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/26/2001	9/26/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MERICA	MERICA	NN	B-NP	O
,	,	,	O	O
RODRICK	RODRICK	NN	B-NP	O
657-85-93-4	657-85-93-4	CD	I-NP	O
No	No	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/16/01	7/16/01	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
echocardiogram	echocardiogram	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MERCARDO	MERCARDO	NN	B-NP	O
,	,	,	O	O
ANTOINE	ANTOINE	NNP	B-NP	O
DARRYL	DARRYL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
45	45	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
h.o.	h.o.	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/12/01	9/12/01	CD	B-NP	O
by	by	IN	B-PP	O
LICHT	LICHT	NNP	B-NP	O
,	,	,	O	O
RUSSELL	RUSSELL	NNP	B-NP	O
P	P	NNP	I-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
47591369	47591369	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/01	9/12/01	CD	B-NP	O
by	by	IN	B-PP	O
RENELL	RENELL	NNP	B-NP	O
,	,	,	O	O
GRANT	GRANT	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
08983648	08983648	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
LOMOTIL	LOMOTIL	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DIPHENOXYLATE	DIPHENOXYLATE	NNP	I-NP	O
W/ATROPINE	W/ATROPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
GLYBURIDE	GLYBURIDE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
NPO	NPO	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/01	9/12/01	CD	B-NP	O
by	by	IN	B-PP	O
ELFORD	ELFORD	NNP	B-NP	O
,	,	,	O	O
CHI	CHI	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
takes	take	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
PLAQUENIL	PLAQUENIL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROXYCHLOROQUINE	HYDROXYCHLOROQUINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-protein
ISORDIL	ISORDIL	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	I-protein
DINITRATE	DINITRATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
95	95	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
95	95	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/01	9/12/01	CD	B-NP	O
by	by	IN	B-PP	O
CHIAMINTO	CHIAMINTO	NNP	B-NP	O
,	,	,	O	O
LAVERN	LAVERN	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q	Q	NNP	I-NP	O
Tu	Tu	NNP	I-NP	O
,	,	,	O	O
Th	Th	NNP	B-NP	O
,	,	,	O	O
Fri	Fri	NNP	B-NP	O
,	,	,	O	O
Sat	Sat	NNP	B-NP	B-protein
,	,	,	O	O
Sun	Sun	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/01	9/12/01	CD	B-NP	O
by	by	IN	B-PP	O
MCFAN	MCFAN	NN	B-NP	B-protein
,	,	,	O	O
FIDEL	FIDEL	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q	Q	NNP	I-NP	O
Mon	Mon	NNP	I-NP	O
,	,	,	O	O
Wed	Wed	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/01	9/12/01	CD	B-NP	O
by	by	IN	B-PP	O
NORMANN	NORMANN	NNP	B-NP	O
,	,	,	O	O
ROCKY	ROCKY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	JJR	B-NP	O
95	95	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
h.o.	h.o.	NN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/16/01	7/16/01	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POSSIBLE	POSSIBLE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Michael	Michael	NNP	I-NP	O
Mcclair	Mcclair	NNP	I-NP	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Sotalol	Sotalol	NN	B-NP	O
,	,	,	O	O
Procainamide	Procainamide	NNP	B-NP	O
,	,	,	O	O
Aspirin	Aspirin	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Quinaglute	Quinaglute	NNP	B-NP	O
,	,	,	O	O
Asa	Asa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
CHF	CHF	NN	I-NP	O
HX	HX	NN	I-NP	O
SYNCOPE	SYNCOPE	NN	I-NP	O
ALL	ALL	NN	I-NP	O
-	-	HYPH	B-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
PCN	PCN	NN	B-NP	O
RA	RA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
St.	St.	NNP	I-NP	O
Jude	Jude	NNP	I-NP	O
MVR	MVR	NNP	I-NP	O
for	for	IN	B-PP	O
MS	MS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
cardiac	cardiac	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hx	Hx	NNP	I-NP	O
AFib/flutte	AFib/flutte	NNP	I-NP	O
r	r	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
IMI	IMI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hx	Hx	NN	I-NP	O
DVT	DVT	NN	I-NP	O
'70	'70	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
appy	appy	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
umbilical	umbilical	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
sigmoidectomy	sigmoidectomy	NN	I-NP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
L	L	NN	I-NP	I-protein
hip	hip	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
'95	'95	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
S/P	S/P	NN	I-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Chronic	Chronic	NNP	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
78	78	CD	B-NP	O
yo	yo	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
A-fib	A-fib	NN	B-NP	B-protein
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
2-3	2-3	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
progressively	progressively	RB	B-VP	O
worsening	worsen	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
evening	evening	NN	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
lasted	last	VBD	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	I-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
and	and	CC	I-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
TNG	TNG	NN	I-NP	B-protein
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
feeling	feel	VBG	I-VP	O
weak/dizzy	weak/dizzy	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
feeling	feel	VBG	I-VP	O
weak	weak	JJ	B-NP	O
and	and	CC	I-NP	O
short	short	JJ	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
so	so	RB	O	O
her	her	PRP$	B-NP	O
minister	minister	NN	I-NP	O
called	call	VBD	B-VP	O
the	the	DT	B-NP	O
paramedics	paramedic	NNS	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
they	they	PRP	B-NP	O
arrived	arrive	VBD	B-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
which	which	WDT	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
her	her	PRP$	B-NP	O
sat	sat	NN	I-NP	O
was	be	VBD	B-VP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
lasix	lasix	CD	B-NP	O
20	20	CD	I-NP	O
IV	IV	CD	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
St.	St.	NNP	B-NP	O
Jude	Jude	NNP	I-NP	O
's	's	POS	B-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
RA	RA	NN	B-NP	O
,	,	,	O	O
sigmoid	sigmoid	JJ	B-NP	O
collectomy	collectomy	NN	I-NP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
Sotalol	Sotalol	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
procainamide	procainamide	NN	B-NP	O
,	,	,	O	O
PCN	PCN	NN	B-NP	B-protein
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
quinaglute	quinaglute	NNP	B-NP	O
MEDS	MEDS	NNP	I-NP	O
:	:	:	O	O
Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
Lomotil	Lomotil	NN	B-NP	O
2	2	CD	I-NP	O
tab	tab	NN	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
,	,	,	O	O
plaquenil	plaquenil	NN	B-NP	O
200	200	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
isordil	isordil	NN	B-NP	O
20	20	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
QTu	QTu	NNP	I-NP	O
,	,	,	O	O
Th	Th	NNP	B-NP	O
,	,	,	O	O
Fr	Fr	NNP	B-NP	O
,	,	,	O	O
Sa	Sa	NNP	B-NP	O
,	,	,	O	O
Su	Su	NNP	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
QMo	QMo	NNP	I-NP	O
,	,	,	O	O
We	We	PRP	B-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
50	50	CD	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	I-NP	O
Norvasc	Norvasc	NNP	I-NP	O
10	10	CD	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
TNG	TNG	NNP	B-NP	O
SHX	SHX	NNP	I-NP	O
:	:	:	O	O
Life	Life	NNP	B-NP	O
long	long	RB	B-NP	O
non-smoker	non-smoker	JJ	I-NP	O
,	,	,	I-NP	O
non-drinker	non-drinker	JJ	I-NP	O
FHX	FHX	NN	I-NP	O
:	:	:	O	O
father	father	NN	B-NP	O
with	with	IN	B-PP	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
mother	mother	NN	B-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	O
Exam	Exam	NN	I-NP	O
:	:	:	O	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
42-60	42-60	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
174/67	174/67	CD	I-NP	I-DNA
,	,	,	O	O
O2	O2	NN	B-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
after	after	IN	B-PP	O
lasix	lasix	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
neck	neck	NN	B-NP	O
exam	exam	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
right	right	JJ	B-NP	O
carotid	carotid	NN	I-NP	O
bruit	bruit	NN	I-NP	O
,	,	,	O	O
8cm	8cm	NN	B-NP	O
JVP	JVP	NNP	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-NP	O
,	,	,	I-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
with	with	IN	B-PP	O
metalic	metalic	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
I/VI	I/VI	NN	B-NP	B-protein
systolic	systolic	JJ	I-NP	I-protein
murmur	murmur	NN	I-NP	I-protein
,	,	,	O	O
+	+	SYM	B-NP	O
S3	S3	NN	I-NP	B-protein
,	,	,	O	O
abdomen	abdoman	NNS	B-NP	O
with	with	IN	B-PP	O
reducible	reducible	JJ	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
extremities	extremity	NNS	B-NP	O
with	with	IN	B-PP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
left	left	JJ	I-NP	O
>	>	SYM	I-NP	O
right	right	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
asymetry	asymetry	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

DATA	DATA	NN	B-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
basline	basline	NN	I-NP	O
~	~	NN	I-NP	O
1.3	1.3	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
31	31	CD	I-NP	I-DNA
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
2.4	2.4	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
with	with	IN	B-PP	O
1st	1st	JJ	B-NP	B-protein
degree	degree	NN	I-NP	I-protein
AVB	AVB	NN	I-NP	I-protein
,	,	,	O	O
rate	rate	NN	B-NP	O
44	44	CD	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
Qwaves	Qwave	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
Twave	Twave	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
with	with	IN	B-PP	O
cardiomegaly	cardiomegaly	NN	B-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
effort	effort	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
Admitted	Admitted	NNP	I-NP	O
to	to	TO	B-PP	O
GMS	GMS	NNP	B-NP	O
Ri	Ri	NNP	I-NP	O
Wood	Wood	NNP	I-NP	O
Rica	Rica	NNP	I-NP	O
,	,	,	O	O
California	California	NNP	B-NP	O
96150	96150	CD	I-NP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Treated	Treat	VBN	B-VP	O
with	with	IN	B-PP	O
lasix	lasix	CD	B-NP	O
20	20	CD	I-NP	O
IV	IV	CD	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
held	hold	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
EF	EF	NN	I-NP	O
around	around	IN	B-PP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
effusion	effusion	NN	I-NP	O
or	or	CC	O	O
new	new	JJ	B-NP	O
valvular	valvular	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
to	to	TO	I-VP	O
home	home	VB	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Deshawn	Deshawn	NNP	I-NP	O
Lannan	Lannan	NNP	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
call	call	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Kehr	Kehr	NNP	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-PP	O
before	before	RB	B-ADVP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
checked	check	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
nurse	nurse	NN	I-NP	O
in	in	IN	B-PP	O
EN	EN	NNP	B-NP	O
COMMUNITY	COMMUNITY	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
worsening	worsen	VBG	I-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
stable	stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TEACHEY	TEACHEY	NNP	B-NP	O
,	,	,	O	O
LAVERNE	LAVERNE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WO56	WO56	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/16/01	7/16/01	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
17	17	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

